Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD

Bone Marrow Transplantation volume 50, pages 3–9 (2015)Cite this article

Subjects

Abstract

Despite similarities relevant age- and gender-specific issues exist in the care of patients after allogeneic hematopoietic SCT (HSCT). Female genital chronic GVHD (cGVHD) has been markedly underreported in the past but has a significant impact on the patients’ health and quality of life. Data on prevention and treatment of this complication are still limited. Here we present a comprehensive review summarizing the current knowledge, which was discussed during several meetings of the German, Austrian and Swiss Consensus Project on clinical practice in cGVHD. In this report, we provide recommendations for post-transplant gynecological care of cGVHD manifestations agreed upon by all participants. This includes guidelines for diagnosis, prevention, and therapeutic options and topical treatments in female patients with genital cGVHD and hormonal replacement treatment of premature ovarian failure for adult and pediatric patients and underlines the necessity for regular gynecological care and screening programs for women after HSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30: 71–77.

    Article  PubMed  Google Scholar 

  2. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006; 12: 138–151.

    Article  PubMed  Google Scholar 

  3. Mertens AC, Ramsay NK, Kouris S, Neglia JP . Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 345–350.

    Article  CAS  PubMed  Google Scholar 

  4. Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB et al. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010; 16: 1611–1628.

    Article  PubMed  Google Scholar 

  5. Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M et al. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 2011; 17: 1–17.

    Article  PubMed  Google Scholar 

  6. Couriel D, Carpenter PA, Cutler C, Bolaňos-Maede J, Treister NS, Gea-Banacloche J et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-ver sus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12: 375–396.

    Article  PubMed  Google Scholar 

  7. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001; 86: 3061–3069.

    CAS  PubMed  Google Scholar 

  8. Pandit L, Ouslander JG . Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997; 314: 228–231.

    CAS  PubMed  Google Scholar 

  9. Suckling J, Lethaby A, Kennedy R . Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006: : CD001500.

  10. Stratton P, Turner ML, Childs R, Barrett J, Bishop M, Wayne AS et al. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol 2007; 110: 1041–1049.

    Article  PubMed  Google Scholar 

  11. Shanis D, Merideth M, Pulanic TK, Savani BN, Battiwalla M, Stratton P . Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. Semin Hematol 2012; 49: 83–93.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chi CC, Kirtschig G, Baldo M, Lewis F, Wang SH, Wojnarowska F . Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. J Am Acad Dermatol 2012; 67: 305–312.

    Article  PubMed  Google Scholar 

  13. Cheng S, Kirtschig G, Cooper S, Thornhill M, Leonardi-Bee J, Murphy R . Interventions for erosive lichen planus affecting mucosal sites. Cochrane Database Syst Rev 2012; 2: CD008092.

    Google Scholar 

  14. Hayes EC, Rock JA . Treatment of vaginal agglutination associated with chronic graft-versus-host disease. Fertil Steril 2002; 78: 1125–1126.

    Article  PubMed  Google Scholar 

  15. Savani BN, Stratton P, Shenoy A, Kozanas E, Goodman S, Barrett AJ . Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation—implications for screening and HPV vaccination. Biol Blood Marrow Transplant 2008; 14: 1072–1075.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 348–371.

    Article  PubMed  Google Scholar 

  17. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12: 31–47.

    Article  PubMed  Google Scholar 

  18. Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0-18 years and adults aged 19 years and older—United States, 2013. MMWR Surveill Summ 2013; 62: 1.

    Google Scholar 

  19. Vujovic S, Brincat M, Erel T, Gambacciani M, Lambrinoudaki I, Moen MH et al. EMAS position statement: Managing women with premature ovarian failure. Maturitas 2010; 67: 91–93.

    Article  PubMed  Google Scholar 

  20. North American Menopause S. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012; 19: 257–271.

    Article  Google Scholar 

  21. Rocca WA, Grossardt BR, Shuster LT . Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res 2011; 1379: 188–198.

    Article  CAS  PubMed  Google Scholar 

  22. Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers ME, Tichelli A et al. Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. Blood. 2008; 111: 939–526.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2011; 117: 1806–1816.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 2009; 113: 1175–1183.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22: 4979–4990.

    Article  PubMed  Google Scholar 

  26. Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS et al. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol 2013; 31: 2282–2288.

    Article  PubMed  Google Scholar 

  27. Couriel DR . Ancillary and supportive care in chronic graft-versus-host disease. Best Pract Res Clin Haematol 2008; 21: 291–307.

    Article  PubMed  Google Scholar 

  28. Corson SL, Sullivan K, Batzer F, August C, Storb R, Thomas ED . Gynecologic manifestations of chronic graft-versus-host disease. Obstet Gynecol 1982; 60: 488–492.

    CAS  PubMed  Google Scholar 

  29. Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB et al. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica 2003; 88: 1163–1168.

    PubMed  Google Scholar 

  30. Spiryda LB, Laufer MR, Soiffer RJ, Antin JA . Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant Dec 2003; 9: 760–765.

    Article  PubMed  Google Scholar 

  31. Zantomio D, Grigg AP, MacGregor L, Panek-Hudson Y, Szer J, Ayton R . Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006; 38: 567–572.

    Article  CAS  PubMed  Google Scholar 

  32. Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  PubMed  Google Scholar 

  33. Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogenic recipients: a long-term follow-up of a randomized trial. Blood 2002; 100: 415–419.

    Article  CAS  PubMed  Google Scholar 

  34. Yanai N, Shufaro Y, Or R, Meirow D . Vaginal outflow tract obstruction by graft-versus-host reaction. Bone Marrow Transplant 1999; 24: 811–812.

    Article  CAS  PubMed  Google Scholar 

  35. DeLord C, Treleaven J, Shepherd J, Saso R, Powles RL . Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia. Bone Marrow Transplant 1999; 23: 523–525.

    Article  CAS  PubMed  Google Scholar 

  36. Filipovich AH, Weisdorf D, Pavletic S, Socié G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  37. Fistarol SK, Itin PH . Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 2013; 14: 27–47.

    Article  PubMed  Google Scholar 

  38. O'Connell TX, Shankar Nathan L, Satmary WA, Goldstein AT . Non-neoplastic epithelial disorders of the vulva. Am Fam Physician 2008; 77: 321–326.

    PubMed  Google Scholar 

  39. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999; 353: 869–873.

  40. Costantini S, Di Capua E, Bosi S, Chiodi S, Spinelli S . The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnosis, surgical technique and follow-up. Minerva Ginecol 2006; 58: 11–16.

    CAS  PubMed  Google Scholar 

  41. Kolb HJ, Socié G, Duell T, Van Lint MT, Tichelli A, Apperley JF et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 1999; 131: 738–744.

    Article  CAS  PubMed  Google Scholar 

  42. Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME et al. Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 2005; 105: 3802–3811.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Savani BN, Goodman S, Barrett AJ . Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? Clin Cancer Res 2009; 15: 2219–2221.

    Article  CAS  PubMed  Google Scholar 

  44. Hilgendorf I, Freund M, Jilg W, Einsele H, Gea-Banacloche J, Greinix H et al. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine 2011; 29: 2825–455 2833.

    Article  PubMed  Google Scholar 

  45. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A et al. Non malignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373–3385.

    Article  PubMed  Google Scholar 

  46. Tauchmanovà L, Selleri C, De Rosa G, Sammartino A, Di Carlo C, Musella T et al. Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review. Menopause 2007; 14: 320–330.

    Article  PubMed  Google Scholar 

  47. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813–818.

    Article  CAS  PubMed  Google Scholar 

  48. Dvorak CC, Gracia CR, Sanders JE, Cheng EY, Baker KS, Pulsipher MA et al. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol Blood Marrow Transplant 2011; 17: 1725–1738.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Cheng YC, Saliba RM, Rondon G, Giralt SA, Lu KH, Bodurka DC et al. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation. Haematologica 2005; 90: 1725–1726.

    PubMed  Google Scholar 

  50. Thygesen KH, Schjodt I, Jarden M . The impact of hematopoetic stem cell transplantation on sexuality: a systematic review of the literature. Bone Marrow Transplant 2012; 47: 716–724.

    Article  CAS  PubMed  Google Scholar 

  51. Piccioni P, Scirpa P, D'Emilio I, Sora F, Scarciglia M, Laurenti L et al. Hormonal replacement therapy after stem cell transplantation. Maturitas 2004; 49: 327–333.

    Article  CAS  PubMed  Google Scholar 

  52. Absolom K, Eiser C, Turner L, Ledger W, Ross R, Davies H et al. Ovarian failure following cancer treatment: current management and quality of life. Hum Reprod 2008; 23: 2506–2512.

    Article  PubMed  Google Scholar 

  53. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM . Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998; 91: 12–15.

    Article  CAS  PubMed  Google Scholar 

  54. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007; 69: 1074–1083.

    Article  CAS  PubMed  Google Scholar 

  55. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT . Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 2006; 13: 265–279.

    Article  PubMed  Google Scholar 

  56. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009; 113: 1027–1037.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004; 89: 3907–3913.

    Article  CAS  PubMed  Google Scholar 

  58. Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation 2005; 111: 1462–1470.

    Article  PubMed  Google Scholar 

  59. Hautmann AH, Elad S, Lawitschka A, Greinix H, Bertz H, Halter J et al. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Transpl Int 2011; 24: 867–879.

    Article  PubMed  Google Scholar 

  60. Tichelli A, Bucher C, Rovo A, Stussi G, Stern M, Paulussen M et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007; 110: 3463–3471.

    Article  CAS  PubMed  Google Scholar 

  61. Maclennan AH, Broadbent JL, Lester S, Moore V . Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004: : CD002978.

  62. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003; 290: 1729–1738.

    Article  CAS  PubMed  Google Scholar 

  63. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333.

    Article  CAS  PubMed  Google Scholar 

  64. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165: 1582–1589.

    Article  CAS  PubMed  Google Scholar 

  65. Bouxsein ML, Chen P, Glass EV, Kallmes DF, Delmas PD, Mitlak BH . Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. J Bone Joint Surg Am 2009; 91: 1329–1338.

    Article  PubMed  Google Scholar 

  66. Vardy MD, Lindsay R, Scotti RJ, Mikhail M, Richart RM, Nieves J et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 2003; 189: 81–88.

    Article  CAS  PubMed  Google Scholar 

  67. Cassidy A, Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I et al. Critical review of health effects of soya bean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006; 65: 76–92.

    Article  CAS  PubMed  Google Scholar 

  68. Leach MJ, Moore V . Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012; 9: CD007244.

    Google Scholar 

  69. Stearns V, Slack R, Greep N, Henry-Tilman R, Osborne M, Bunnell C et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005; 23: 6919–6930.

    Article  CAS  PubMed  Google Scholar 

  70. Salooja N, Szydlo RM, Socié G, Rio B, Chatterjee R, Ljungman P et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 2001; 358: 271–276.

    Article  CAS  PubMed  Google Scholar 

  71. Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 2011; 17: 157–166.

    Article  PubMed  Google Scholar 

  72. Jeruss JS, Woodruff TK . Preservation of fertility in patients with cancer. N Engl J Med 2009; 360: 902–911.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Pierce AM, Hart CA . Vulvovaginitis: causes and management. Arch Dis Child 1992; 67: 509–512.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Ranđelović G, Mladenović V, Ristić L, Otašević S, Branković S, Mladenović-Antić S et al. Microbiological aspects of vulvovaginitis in prepubertal girls. Eur J Pediatr 2012; 171: 1203–1208.

    Article  PubMed  Google Scholar 

  75. Bumbulienė Ž, Venclavičiūtė K, Ramašauskaite D, Arlauskiene A, Bumbul E, Drąsutiene G . Microbiological findings of vulvovaginitis in prepubertal girls. Postgrad Med J 2014; 90: 8–12.

    Article  PubMed  Google Scholar 

  76. Dei M, Di Maggio F, Di Paolo G, Bruni V . Vulvovaginitis in childhood. Best Pract Res Clin Obstet Gynaecol 2010; 24: 129–137.

    Article  PubMed  Google Scholar 

  77. Van Eyk N, Allen L, Giesbrecht E, Jamieson MA, Kives S, Morris M et al. Pediatric vulvovaginal disorders: a diagnostic approach and review of the literature. J Obstet Gynaecol Can 2009; 31: 850–862.

    Article  Google Scholar 

  78. Sybert VP, McCauley E . Turner’s syndrome. N Engl J Med 2004; 351: 1227–1238.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Women’s Hospital, Cantonal Hospital Baselland, Bruderholz, Switzerland

    B Frey Tirri

  2. Department of Dermatology, University Hospital Basel, Basel, Switzerland

    P Häusermann

  3. Department of Hematology and Oncology, Albert Ludwigs-University Medical Center, Freiburg, Germany

    H Bertz

  4. Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria

    H Greinix

  5. St Anna Children’s Hospital, Medical University of Vienna, Vienna, Austria

    A Lawitschka

  6. University Children’s Hospital Tuebingen, Tuebingen, Germany

    C-P Schwarze

  7. Department of Medicine III, University of Regensburg, Regensburg, Germany

    D Wolff

  8. Department of Hematology, University Hospital Basel, Basel, Switzerland

    J P Halter

  9. Department of General Gynecology and Gynecological Oncology, Medical University of Vienna, Vienna, Austria

    D Dörfler

  10. Clinic for Gynecological Endocrinology and Reproductive Medicine, University Hospital Basel, Basel, Switzerland

    R Moffat

  11. Fertisuisse, Center for Reproductive Medicine, Olten, Switzerland

    R Moffat

Authors
  1. B Frey Tirri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Häusermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Bertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Greinix
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Lawitschka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C-P Schwarze
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Wolff
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J P Halter
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D Dörfler
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R Moffat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to B Frey Tirri or R Moffat.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frey Tirri, B., Häusermann, P., Bertz, H. et al. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD. Bone Marrow Transplant 50, 3–9 (2015). https://doi.org/10.1038/bmt.2014.242

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.242

This article is cited by

Search

Advanced search

Quick links